alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT32.2**

 

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report of Candela Corporation (the“Company”) on Form 10-Q for the period ended September 27, 2003 as filedwith the Securities and Exchange Commission on the date hereof (the “Report”),I, F. Paul Broyer, Chief Financial Officer of the Company, certify, pursuant to18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-OxleyAct of 2002, that:

 

(1) The Report fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;and

 

(2) The information contained in the Report fairly presents, in allmaterial respects, the financial condition and result of operations of theCompany.

 
| Date:  | November 10, 2003  |   | /s/ F. Paul Broyer |   |
|--------|-------------------------|--------|--------------------|--------|
|   | F. Paul Broyer          |
|   | Chief Financial Officer |

 

----
Exhibit 31.2

Certification of CFO pursuant to Securities Exchange Act rules 13a-15 and
15d-15(c) as adopted pursuant to section 302 of the Sarbanes-Oxley act of 2002.

I, Robert Genesi, certify that:

1. I have reviewed this report on Form 10-QSB of GTDATA Corporation (the
"Registrant");

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report.

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15 and 15d-15(c)) for the registrant and have: a)
designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared; b) evaluated the
effectiveness of the registrant's disclosure controls and procedures and
presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures as of a date within 90 days prior to the
filing date of this quarterly report (the "Evaluation Date"); and c) presented
in this quarterly report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
the registrant's board of directors (or persons performing the equivalent
functions): a) all significant deficiencies in the design or operation of
internal controls which are reasonably likely to adversely affect the
registrant's ability to record, process, summarize and report financial data and
have identified for the registrant's auditors any material weaknesses in
internal controls; and b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant's
internal controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: November 19, 2003

/S/ ROBERT GENESI
-------------------
ROBERT GENESI
CHIEF FINANCIAL OFFICER
(PRINCIPAL ACCOUNTING OFFICER)
# C_2006057EN.01002601.xml

| 9.3.2006 | EN | Official Journal of the European Union | C 57/26 |
| --- | --- | --- | --- |

9.3.2006

EN

Official Journal of the European Union

C 57/26

---

Authorisation of State measure pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part I of Protocol 3 to the Surveillance and Court Agreement

(2006/C 57/11)

The EFTA Surveillance Authority has decided not to raise objections to the notified measure.

Date of adoption:

EFTA State: Norway

Aid No: 55211

Title: EFTA Surveillance Authority decision of 15 July 2005 on the notification of a new risk capital scheme: Regional seed capital investment scheme for assisted areas

Objective: To increase the supply of seed capital and to promote the development of assisted areas

Legal basis: St.prp. nr. 65 (2002-2003), inst. S. nr. 260 (2002-2003), St.prp. nr. 1 (2003-2004), Budsjett-innst. S. nr. 8 (2003-2004), St.prp. nr.1 Tillegg nr. 1 (2004-2005, St.prp. nr. 16 (2004-2005, Budsjett-innst. S.nr. 8 (2004-2005) and Budsjett-innst. S. nr. 8 (2004-2005)

Duration: Up to 15 years

Budget: Subordinated loans of NOK 700 million (approximately EUR 85 million), administrative costs of NOK 50 million (approximately EUR 6,1 million) and a loss-fund of NOK 175 million (approximately EUR 21 million)

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM SEC FORM 10Q AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          JUL-01-2000             JUL-03-1999
<PERIOD-END>                               OCT-02-1999             SEP-26-1998
<CASH>                                          29,538                   2,463
<SECURITIES>                                         0                       0
<RECEIVABLES>                                   13,796                   9,529
<ALLOWANCES>                                     1,205                   1,095
<INVENTORY>                                      6,639                   7,133
<CURRENT-ASSETS>                                52,238                  20,131
<PP&E>                                           7,776                   7,718
<DEPRECIATION>                                   5,256                   4,906
<TOTAL-ASSETS>                                  56,932                  23,424
<CURRENT-LIABILITIES>                           16,389                  16,211
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                               73                      55
<PREFERRED>                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                      37,354                   6,666
<TOTAL-LIABILITY-AND-EQUITY>                    56,932                  23,424
<SALES>                                         16,040                  10,738
<TOTAL-REVENUES>                                16,259                  10,749
<CGS>                                            9,141                   5,674
<TOTAL-COSTS>                                    9,141                   5,674
<OTHER-EXPENSES>                                 5,982                   3,987
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 233                      78
<INCOME-PRETAX>                                  3,392                   1,010
<INCOME-TAX>                                       678                     100
<INCOME-CONTINUING>                              2,714                     910
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     2,714                     910
<EPS-BASIC>                                       0.40                    0.17
<EPS-DILUTED>                                     0.35                    0.16


</TABLE>
#### § 1263.25 [Reserved]
§ 24.7 Examination, records, and remedial action. ( a ) *Examination.* National bank investments under this part are subject to the examination provisions of 12 U.S.C. 481.
( b ) *Records.* Each national bank shall maintain in its files information adequate to demonstrate that its investments meet the standards set out in § 24.3 of this part, including, where applicable, the criteria of § 25.23 of appendix G to 12 CFR part 25, and that the bank is otherwise in compliance with the requirements of this part.
( c ) *Remedial action.* If the OCC finds that an investment under this part is in violation of law or regulation, is inconsistent with the safe and sound operation of the bank, or poses a significant risk to a Federal deposit insurance fund, the national bank shall take appropriate remedial action as determined by the OCC.
[61 FR 49660, Sept. 23, 1996, as amended at 68 FR 48777, Aug. 15, 2003; 89 FR 22067, Mar. 29, 2024]
Order entered September 4, 2018 

In The 

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-00993-CV 

No. 05-18-00994-CV 

IN RE SHEMONT JAYRON GULLATT, Relator 

Original Proceeding from the 363rd Judicial District Court 

Dallas County, Texas 

Trial Court Cause Nos. F-11-61616-W and F-11-70820-W 

ORDER 

Before Justices Bridges, Brown, and Boatright 

Based on the Court’s opinion of this date, we DENY relator’s petition for writ of 

mandamus. 

/s/ DAVID L. BRIDGES 

 JUSTICE
HomeReportsBureau of Economic and Business Affairs2023 Fiscal Transparency Report…Dominican Republic

# 					2023 Fiscal Transparency Report: Dominican Republic			

 In this section										

                -  Government-by-Government Assessments: Dominican Republic 

## Government-by-Government Assessments: Dominican Republic

During the review period, the government published an executive budget proposal, enacted budget, and end-of-year report online within a reasonable period.Budget and information on debt obligations were widely and easily accessible to the public, including online.The enacted budget was substantially complete and considered generally reliable.The end-of-year report, however, was incomplete.The budget did not include allocations to and earnings from major state-owned enterprises.The supreme audit institution did not meet international standards of independence.While it published an audit that covered the entire annual executed budget, the audit report did not contain substantive findings or recommendations.The government specified in law or regulation and appeared to follow in practice the criteria and procedures for awarding natural resource extraction contracts and licenses.Basic information on natural resource extraction awards was public.

The Dominican Republic’s fiscal transparency would be improved by:

-  Publishing a comprehensive end-of-year report;
-  Publishing budget allocations to, earnings from, and debt of major state-owned enterprises;
-  Ensuring the supreme audit institution meets international standards of independence; and
-  Ensuring audit reports contain substantive findings.

## View report by:

### On This Page

                    -  Government-by-Government Assessments: Dominican Republic 

Tags

Bureau of Economic and Business AffairsBureau of Western Hemisphere AffairsDivision for International Finance and DevelopmentDominican Republic

Back to Top

                - White House
                - USA.gov
                - Office of the Inspector General
                - Archives
                - Contact Us

follow us
FacebookXInstagramYouTubeFlickrGovDelivery

              - Privacy Policy
              - Accessibility Statement
              - Copyright Information
              - FOIA
              - No FEAR Act

## U.S. Department *of* State

#### The Lessons of 1989: Freedom and Our Future
EXHIBIT 10.52



[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed
separately with the Securities And Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.



November 30, 2005



Chris Penland, Ph.D.

Cystic Fibrosis Foundation Therapeutics, Inc.

6931 Arlington Road

Bethesda, MD 20814



Dear Dr. Penland:



The purpose of this letter (Letter) is to amend the Study Funding Agreement, between the undersigned parties, dated June 17, 2003, as
amended (the Agreement). By signing below, the undersigned parties agree to the following:



In Section 8.1(c) of the Agreement, [ * ] shall be replaced with [ * ].



All other terms and provisions of the Agreement shall remain unchanged and
are in full force and effect.



|                                  |  |                                                 |  |  |  |                         |  | 
|--------------------------------- |  | ----------------------------------------------- |  |  |  | ----------------------- |  | 
|HOLLIS-EDEN PHARMACEUTICALS, INC. |  |                                                 |  | 
|                                  |  |                                                 | 
|By:                               |  | /s/    ERIC J. LOUMEAU                          |  |  |  | Date: December 13, 2005
|                                  |  | Eric J. Loumeau Vice President, General Counsel |  |  |  |                         |  | 



Agreed to and Acknowledged by:



|                                              |  |                                          |  |  |  |                        |  | 
|--------------------------------------------- |  | ---------------------------------------- |  |  |  | ---------------------- |  | 
|CYSTIC FIBROSIS FOUNDATION THERAPEUTICS,
INC. |  |                                          |  | 
|                                              |  |                                          | 
|By:                                           |  | /s/    ROBERT J. BEALL                   |  |  |  | Date: December 9, 2005
|                                              |  | Robert J. Beall, Ph.D. President and CEO |  |  |  |                        |  |
EXHIBIT
32



CERTIFICATIONS
PURSUANT TO

SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002

(18
U.S.C. SECTION 1350)



In
connection with the quarterly report of Cala Corporation on Form 10-Q
for the quarter ended September 30, 2010, as filed with the
Securities and Exchange Commission (the "Report") Joseph
Cala, Chief Executive Officer and Chief Financial Officer of the
Company, does hereby certify, pursuant to §906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350), that to his
knowledge:



1.
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and



2.
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation
of the Company.



|Date: June 27, 2011 | By: /s/ Joseph Cala                                           
|------------------- | --------------------------------------------------------------
|                    | Joseph Cala                                                   
|                    | Principal
			Executive Officer and Principal Financial Officer



This
certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent
required by the Sarbanes-Oxley Act of 2002, be deemed filed by the
Company for purposes of Section 18 of the Securities Exchange Act of
1934, as amended.
§ 215.7 Extensions of credit outstanding on March 10, 1979. ( a ) Any extension of credit that was outstanding on March 10, 1979, and that would, if made on or after March 10, 1979, violate § 215.4(c) of this part, shall be reduced in amount by March 10, 1980, to be in compliance with the lending limit in § 215.4(c) of this part. Any renewal or extension of such an extension of credit on or after March 10, 1979, shall be made only on terms that will bring the extension of credit into compliance with the lending limit of § 215.4(c) of this part by March 10, 1980. However, any extension of credit made before March 10, 1979, that bears a specific maturity date of March 10, 1980, or later, shall be repaid in accordance with its repayment schedule in existence on or before March 10, 1979.
( b ) If a member bank is unable to bring all extensions of credit outstanding on March 10, 1979, into compliance as required by paragraph (a) of this section, the member bank shall promptly report that fact to the Comptroller of the Currency, in the case of a national bank, or to the appropriate Federal Reserve Bank, in the case of a State member bank, and explain the reasons why all the extensions of credit cannot be brought into compliance. The Comptroller or the Reserve Bank, as the case may be, is authorized, on the basis of good cause shown, to extend the March 10, 1980, date for compliance for any extension of credit for not more than two additional one-year periods.
[Federal Register Volume 74, Number 193 (Wednesday, October 7, 2009)]
[Notices]
[Page 51661]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24110]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of Taxpayer Advocacy Panel Notice Improvement Issue 
Committee

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Taxpayer Advocacy Panel Notice 
Improvement Issue Committee will be conducted. The Taxpayer Advocacy 
Panel is soliciting public comments, ideas and suggestions on improving 
customer service at the Internal Revenue Service.

DATES: The meeting will be held Thursday, November 12, 2009.

FOR FURTHER INFORMATION CONTACT: Sallie Chavez at 1-888-912-1227, or 
954-423-7979.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to section 
10 (a) (2) of the FederalAdvisory Committee Act, 5 U.S.C. App. (1988) 
that an open meeting of the Taxpayer Advocacy Panel Notice Improvement 
Issue Committee will be held Thursday, November 12, 2009, at 2 p.m. 
Eastern Time via telephone conference. The public is invited to make 
oral comments or submit written statements for consideration. Due to 
limited conference lines, notification of intent to participate must be 
made with Sallie Chavez. For more information please contact Ms. Chavez 
at 1-888-912-1227 or 954-423-7979, or write TAP Office, 1000 South Pine 
Island Road, Suite 340, Plantation, FL 33324, or post comments to the 
Web site: http:[sol][sol]www.improveirs.org.
    The agenda will include various IRS issues.

    Dated: October 1, 2009.
Shawn F. Collins,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. E9-24110 Filed 10-6-09; 8:45 am]
BILLING CODE 4830-01-P
#### § 1271.31 General authority.

Subject to the limitations and interpretations in this subpart and such orders and directions as FHFA may prescribe, the Financing Corporation shall have authority to exercise all powers and authorities granted to it by the Bank Act and by its charter and bylaws regardless of whether the powers and authorities are specifically implemented in regulation.
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 263 Introduced in House (IH)]

108th CONGRESS
  1st Session
                                H. R. 263

  To amend title 38, United States Code, to improve access to medical 
   services for veterans seeking treatment at Department of Veterans 
  Affairs outpatient clinics with exceptionally long waiting periods.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 8, 2003

  Mr. Duncan introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
  To amend title 38, United States Code, to improve access to medical 
   services for veterans seeking treatment at Department of Veterans 
  Affairs outpatient clinics with exceptionally long waiting periods.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

     This Act may be cited as the ``Veterans Outpatient Care Access Act 
of 2003''.

SEC. 2. ACCESS TO MEDICAL SERVICES FOR VETERANS SEEKING TREATMENT AT 
              DEPARTMENT OF VETERANS AFFAIRS OUTPATIENT CLINICS WITH 
              EXCEPTIONALLY LONG WAITING PERIODS.

    (a) Access to Care.--Section 1710 of title 38, United States Code, 
is amended by adding at the end the following new subsection:
    ``(i) In the case of an outpatient clinic of the Department at 
which the waiting period for treatment of patients is six months or 
longer, the Secretary shall, for any veteran seeking medical services 
at that clinic who is informed by the clinic that the veteran will have 
such a waiting period, provide for the provision of needed medical 
services for that veteran from sources outside the Department. 
Provision of such services shall be under the same terms and conditions 
with respect to eligibilty and copayments (if any) as apply if such 
services were provided directly by the Secretary through the clinic. 
The Secretary shall prescribe such regulations as necessary to carry 
out this subsection.''.
    (b) Effective Date.--Subsection (i) of section 1710 of title 38, 
United States Code, shall take effect at the end of the 90-day period 
beginning on the date of the enactment of this Act.
                                 <all>
```